BioPharma Coverage - MedCity News
WEBIn a Phase 3 study, Eli Lilly’s tirzepatide led to a 94% reduction in the risk that obese or overweight prediabetes patients progress to type 2 diabetes. Lilly was already planning to expand use ...
MedCity Knowledge Hub - MedCity Knowledge Hub
WEBOur library of free downloadable content includes white papers, webinars, product guides, case studies, industry analysis and much more, provided by experts and vendors within the healthcare industry. By downloading the content, you may be contacted by the provider. For more information on posting content in the Knowledge Hub, please click here.
Innovaccer Coverage - MedCity News
WEBInnovaccer valued at $3.2B in most recent fundraise. The company, which is building a cloud-based platform to help health systems pull health records together, recently closed a $150 million ...
Insmed’s Trial Results Pave Way for FDA Filing in a Lung Disease …
WEBMay 28, 2024 · Insmed reported that the low dose of brensocatib led to a 21.1% reduction in the rate of pulmonary exacerbations compared to placebo measured at 52 weeks; the high dose achieved a 19.4% reduction.
Improving outcomes, speeding up diagnoses among goals of …
WEBApr 4, 2013 · Philadelphia has reached a new milestone in the drive to build its startup healthcare ecosystem. DreamIt Health’s inaugural class includes 10 startups.The four-month program co-sponsored by ...
Main Street Health Rakes In $315M to Scale Value-Based Care in …
WEBOct 10, 2023 · Over the past few years, there’s been a notable surge in investment dollars directed towards companies specializing in value-based care. Investment in companies that enable value-based care ...
Amgen Coverage - MedCity News
WEBAmgen and the Federal Trade Commission are settling the lawsuit the regulator filed to block the pharmaceutical giant’s $28 billion Horizon Therapeutics acquisition. As part of the settlement ...
Subscribe - MedCity News
WEBSubscribe to Our Email Newsletters. Be the first to hear the latest industry news from across the country by receiving the daily MedCity email newsletter. By providing some extra detail below we ...
Evaluation of the use of midline peripheral catheters for the …
WEBJun 10, 2021 · The purpose of this study was to assess the processes and outcomes of using the MC to sample blood for laboratory testing. We aimed to evaluate the MC in an acute care setting for hemolysis rates ...
Why Medtronic decided to move now on its $1.1B Intersect ENT deal
WEBThat is the case with Medtronic’s recently-announced $1.1 billion acquisition of Intersect. Medtronic actually invested in the company back in 2010, according to John Jordan, director of ...